Citi Pharma (KAR:CPHL) NonCurrent Deferred Liabilities : ₨0.00 Mil (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Citi Pharma's non-current deferred liabilities for the quarter that ended in . 20 was ₨0.00 Mil.

Citi Pharma NonCurrent Deferred Liabilities Historical Data

The historical data trend for Citi Pharma's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma NonCurrent Deferred Liabilities Chart

Citi Pharma Annual Data

Trend

NonCurrent Deferred Liabilities

Citi Pharma Semi-Annual Data

NonCurrent Deferred Liabilities

Citi Pharma NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Citi Pharma's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » NonCurrent Deferred Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

588 Q Block, Johar Town, Lahore, PB, PAK

Website

http://www.citipharma.com.pk

Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines